Digestion GB
Natural health product licensed in Canada
- Other names
- Pure Encapsulations Digestion GB
- Licence holder
- Pure Encapsulations
- NPN or DIN-HM
- 80132627
- Status
- Inactive licence
- Licence date
- 18 July 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Silybum marianum Source : Silybum marianum - Graine Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 1,125 mg Potency : 80 % Silymarin | 75 mg | Not calculated |
| Silybum marianum Source : Silybum marianum - Graine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 2,250 mg | Not specified | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 10 mg | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 7,500 FCC LU | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,250 mg | Not specified | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg | 50 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 10 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Palmitate d'ascorbyle, Hypromellose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Curcuma longa is traditionally used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Curcuma longa is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia (carminative) and aid digestion. Used in Herbal Medicine to help relieve flatulent dyspepsia (carminative) and aid digestion. Curcuma longa is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Source of/Provides antioxidants. Curcuma longa is traditionally used in Ayurveda to relieve pain and inflammation. Used in Herbal Medicine as a hepatoprotectant/liver protectant. Used in Herbal Medicine to aid digestion, increase bile excretion by the liver and stimulate the gallbladder. Used in Herbal Medicine to aid digestion. Used in Herbal Medicine to increase bile excretion by the liver (choleretic) and stimulate contraction of the gallbladder (cholagogue). Digestive Aid. Digestive aid to help digest proteins. Digestive enzyme that helps digest proteins. Digestive enzyme. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132627
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.